Cleo Diagnostics Ltd has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CLEO Diagnostics
Later from CLEO Diagnostics
- Completion of First Triage Test Clinical Validation Study
- Cleo Completes Design Transfer
- Peer-Review Supports CLEOs Ovarian Cancer Detection Tech
- CLEO Appoints Partner to Commence U.S. Market Access Program
- COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics